EconPapers    
Economics at your fingertips  
 

Mrc1 (MMR, CD206) controls the blood proteome in reducing inflammation, age-associated organ dysfunction and mortality in sepsis

Damien Restagno, Mayank Saraswat, Peter V. Aziz, Kathryn Smith, Amanda J. Roberts, John Hintze () and Jamey D. Marth ()
Additional contact information
Damien Restagno: Sanford-Burnham-Prebys Medical Discovery Institute
Mayank Saraswat: Sanford-Burnham-Prebys Medical Discovery Institute
Peter V. Aziz: Sanford-Burnham-Prebys Medical Discovery Institute
Kathryn Smith: Sanford-Burnham-Prebys Medical Discovery Institute
Amanda J. Roberts: Scripps Research Institute
John Hintze: Sanford-Burnham-Prebys Medical Discovery Institute
Jamey D. Marth: Sanford-Burnham-Prebys Medical Discovery Institute

Nature Communications, 2025, vol. 16, issue 1, 1-13

Abstract: Abstract Circulating blood proteins and enzymes are maintained within normal physiological and clinically relevant concentration ranges. Excursions from normality include diagnostic markers and causes of disease. Rapid and persistent changes in the levels and functions of circulating blood components can reflect the functions of multiple endocytic lectin receptors. The majority of non-albumin blood proteins are post-translationally modified with sialylated N-glycans bearing cryptic ligands of various endocytic lectin receptors. During time in circulation, these cryptic ligands are progressively unmasked thereby contributing to glycoprotein half-life and abundance. The relationships between distinct lectin receptors and their endogenous ligand repertoires are not easily established. Herein we apply a glycosidic linkage enrichment strategy to identify accumulating mannosylated plasma glycoproteins linked to the absence of the endocytic Mrc1 (MMR, CD206) mannose-binding lectin receptor. We find that Mrc1 controls the abundance of over two hundred circulating endogenous mannosylated proteins in healthy mice at steady state, including glycoproteins linked to inflammation, age-associated organ dysfunction, and elevated mortality in sepsis. Increased circulating Mrc1 levels previously ascribed to proteolysis during sepsis are proportional to mannosylated protein accumulation in the blood. Assignment of circulating mannosylated proteins to curated biological and pathogenic signaling pathways reveals significant overlap between Mrc1 dysfunction and human sepsis.

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-025-61346-4 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-61346-4

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-025-61346-4

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-07-09
Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-61346-4